Yang Lu, Xinyi Chen, Wenjing Zeng, Ping Hua, Yangmei Shen, Yan Qiu, Xin He, Hongying Zhang
{"title":"COL1A1::具有TERT启动子突变的PDGFB融合子宫肉瘤。","authors":"Yang Lu, Xinyi Chen, Wenjing Zeng, Ping Hua, Yangmei Shen, Yan Qiu, Xin He, Hongying Zhang","doi":"10.1002/gcc.23210","DOIUrl":null,"url":null,"abstract":"<p><i>COL1A1::PDGFB</i> fusion uterine sarcoma is a rare uterine mesenchymal tumor with some clinicopathological features that overlap with those of soft tissue dermatofibrosarcoma protuberans. However, the varied clinicopathologic and genetic characteristics have not been fully revealed, which may be a potential pitfall for diagnosis. Here, we present a case of <i>COL1A1::PDGFB</i> fusion-positive uterine sarcoma in a 49-years-old female. Histologically, the tumor from the initial marginal excision predominantly exhibited high-grade fibrosarcomatous and myxofibrosarcoma-like appearances, while a low-grade focal area displaying storiform growth was identified in the residual tumor after subsequently extended resection. Immunohistochemically, the high-grade components mainly exhibited focal positivity for CD34 and mutated-type p53 immunoreactivity, whereas the low-grade component showed diffuse positivity for CD34 and wild-type p53 staining. The <i>COL1A1::PDGFB</i> fusion was confirmed by fluorescence in situ hybridization and next-generation sequencing. In addition, the <i>TERT</i>-124 C > T mutation was further identified in this lesion's fibrosarcomatous and classic storiform components. To the best of our knowledge, this is the first described case of <i>COL1A1::PDGFB</i> fusion uterine sarcoma with a <i>TERT</i> promoter mutation, which might be a novel genetic finding associated with tumorigenesis of this rare tumor.</p>","PeriodicalId":12700,"journal":{"name":"Genes, Chromosomes & Cancer","volume":"63 1","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2023-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"COL1A1::PDGFB fusion uterine sarcoma with a TERT promoter mutation\",\"authors\":\"Yang Lu, Xinyi Chen, Wenjing Zeng, Ping Hua, Yangmei Shen, Yan Qiu, Xin He, Hongying Zhang\",\"doi\":\"10.1002/gcc.23210\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><i>COL1A1::PDGFB</i> fusion uterine sarcoma is a rare uterine mesenchymal tumor with some clinicopathological features that overlap with those of soft tissue dermatofibrosarcoma protuberans. However, the varied clinicopathologic and genetic characteristics have not been fully revealed, which may be a potential pitfall for diagnosis. Here, we present a case of <i>COL1A1::PDGFB</i> fusion-positive uterine sarcoma in a 49-years-old female. Histologically, the tumor from the initial marginal excision predominantly exhibited high-grade fibrosarcomatous and myxofibrosarcoma-like appearances, while a low-grade focal area displaying storiform growth was identified in the residual tumor after subsequently extended resection. Immunohistochemically, the high-grade components mainly exhibited focal positivity for CD34 and mutated-type p53 immunoreactivity, whereas the low-grade component showed diffuse positivity for CD34 and wild-type p53 staining. The <i>COL1A1::PDGFB</i> fusion was confirmed by fluorescence in situ hybridization and next-generation sequencing. In addition, the <i>TERT</i>-124 C > T mutation was further identified in this lesion's fibrosarcomatous and classic storiform components. To the best of our knowledge, this is the first described case of <i>COL1A1::PDGFB</i> fusion uterine sarcoma with a <i>TERT</i> promoter mutation, which might be a novel genetic finding associated with tumorigenesis of this rare tumor.</p>\",\"PeriodicalId\":12700,\"journal\":{\"name\":\"Genes, Chromosomes & Cancer\",\"volume\":\"63 1\",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2023-10-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Genes, Chromosomes & Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/gcc.23210\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genes, Chromosomes & Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/gcc.23210","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
摘要
COL1A1::PDGFB融合子宫肉瘤是一种罕见的子宫间充质肿瘤,其一些临床病理特征与隆起的软组织皮肤纤维肉瘤的临床病理特征重叠。然而,各种临床病理和遗传特征尚未完全揭示,这可能是诊断的一个潜在陷阱。在此,我们报告一例49岁女性COL1A1::PDGFB融合阳性子宫肉瘤。组织学上,最初边缘切除的肿瘤主要表现为高级别纤维肉瘤和黏液纤维肉瘤样外观,而在随后的扩大切除后,残留肿瘤中发现了一个低级别的局灶区域,显示出树状生长。免疫组化显示,高级别组分主要表现出CD34和突变型p53免疫反应性的局灶性阳性,而低级别组分表现出CD33和野生型p53染色的弥漫性阳性。COL1A1::PDGFB融合通过荧光原位杂交和下一代测序得到证实。此外,TERT-124 C > T突变在该病变的纤维肉瘤和典型的存储器状成分中得到进一步鉴定。据我们所知,这是第一例描述的具有TERT启动子突变的COL1A1::PDGFB融合子宫肉瘤,这可能是一种与这种罕见肿瘤的发生相关的新的遗传发现。
COL1A1::PDGFB fusion uterine sarcoma with a TERT promoter mutation
COL1A1::PDGFB fusion uterine sarcoma is a rare uterine mesenchymal tumor with some clinicopathological features that overlap with those of soft tissue dermatofibrosarcoma protuberans. However, the varied clinicopathologic and genetic characteristics have not been fully revealed, which may be a potential pitfall for diagnosis. Here, we present a case of COL1A1::PDGFB fusion-positive uterine sarcoma in a 49-years-old female. Histologically, the tumor from the initial marginal excision predominantly exhibited high-grade fibrosarcomatous and myxofibrosarcoma-like appearances, while a low-grade focal area displaying storiform growth was identified in the residual tumor after subsequently extended resection. Immunohistochemically, the high-grade components mainly exhibited focal positivity for CD34 and mutated-type p53 immunoreactivity, whereas the low-grade component showed diffuse positivity for CD34 and wild-type p53 staining. The COL1A1::PDGFB fusion was confirmed by fluorescence in situ hybridization and next-generation sequencing. In addition, the TERT-124 C > T mutation was further identified in this lesion's fibrosarcomatous and classic storiform components. To the best of our knowledge, this is the first described case of COL1A1::PDGFB fusion uterine sarcoma with a TERT promoter mutation, which might be a novel genetic finding associated with tumorigenesis of this rare tumor.
期刊介绍:
Genes, Chromosomes & Cancer will offer rapid publication of original full-length research articles, perspectives, reviews and letters to the editors on genetic analysis as related to the study of neoplasia. The main scope of the journal is to communicate new insights into the etiology and/or pathogenesis of neoplasia, as well as molecular and cellular findings of relevance for the management of cancer patients. While preference will be given to research utilizing analytical and functional approaches, descriptive studies and case reports will also be welcomed when they offer insights regarding basic biological mechanisms or the clinical management of neoplastic disorders.